Last modified: January 9, 2010
Offices[edit]
People[edit]
Web Presences[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
|
|
Description[edit]
CrystalGenomics is a leading structure-based drug discovery and development company headquartered in Seoul, Korea with a US presence (CG Pharmaceuticals, Inc) in Emeryville, California.
The company has a diverse pipeline in the disease areas of inflammation, anti-infectives and cancer. They include next generation NSAID, CG100649 which has successfully finished Phase 2a and two other pre-clinical candidates of a novel antibiotics for MRSA and VRSA, CG400549 and an oral/IV HDAC inhibitor for cancer, CG200745.
The Company has established several drug discovery collaborations with leading pharmas and VC groups, including Daiichi-Sankyo, SBI-Biotech, Carna Biosciences, Yuyu Pharma, AmorePacific, Hanmi Pharmaceuticals and ProQuest Investments. CrystalGenomics is publicly-held with a listing on the KOSDAQ exchange (Seoul, Korea)
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| CRYSTALGENOMICS Job Trends | CRYSTALGENOMICS Jobs |
- Biotech Showcase 2010 - Presenting Companies (3 subscribers)
This Company is Being Watched in
Recent Updates |
|---|
| CRYSTALGENOMICS has been added to the Ecosystem. |